ITGAM and neoplasm: Flow cytometric analysis showed that ASIV treatment decreased the proportion of CD11b+ F4/80+ CD206+ M2 macrophages, while the proportion of CD11b+ F4/80+ MHCII+ M1 macrophages increased in tumor tissue, further confirming the shift from M2 to M1 polarization in vivo.